Test Price
2,800 AED✅ Home Collection Available
MYH2 Gene Inclusion Body Myopathy Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MYH2 لاعتلال عضلي جسمي مشتمل بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي | Executive Summary
دقة تشخيصية 99.9% عبر معالجة معتمدة بموجب ISO 9001:2015. خدمة سحب الدم المنزلية الفاخرة بسلسلة تبريد معتمدة. استشارة هاتفية بعد الاختبار لتفسير النتائج. التحقق من تغطية التأمين عبر واتساب: +971545488731. امتثال كامل للمرسوم بقانون اتحادي رقم 41 لسنة 2024 (المادة 87)، وقانون الخدمات السريرية التشخيصية 2026 للقُصَّر، وقانون حماية البيانات الشخصية الإماراتي.
Diagnostic accuracy: 99.9% sensitivity via ISO 9001:2015‑accredited processing. Premium hospital‑grade home blood collection with cold‑chain logistics. Post‑test telephonic clinical guidance for result interpretation. Direct insurance billing verification via WhatsApp: +971545488731. Fully compliant with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (minors), and UAE PDPL.
Overview of the MYH2 Gene Inclusion Body Myopathy DNA Test
This advanced next‑generation sequencing (NGS) test comprehensively analyzes the entire coding region of the MYH2 gene to identify pathogenic variants responsible for hereditary inclusion body myopathy. The single‑gene NGS approach provides a definitive molecular diagnosis with class‑leading accuracy, guiding personalized neurology management, genetic counseling, and family risk assessment.
| Feature | Our NGS Test (MYH2 Single‑Gene) | Closest Alternative (Conventional Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – covers all exons, intron‑exon boundaries, and known deep intronic variants | Sanger sequencing – typically performed exon‑by‑exon, limited to pre‑selected regions |
| Variant Coverage | >99% of the coding region plus splice sites; simultaneous detection of single nucleotide variants, small indels, and copy number changes | Targeted analysis of specific exons; deletions/duplications rarely detected without additional MLPA assay |
| Turnaround Time | 3 to 4 weeks | 6 to 8 weeks (often requiring multiple rounds) |
| Cost in UAE | 2,800 AED (all‑inclusive) | 3,500–4,200 AED (depending on number of exons) |
| Clinical Confidence | Gold‑standard resolution – ideal for diagnostic confirmation and family screening | Lower diagnostic yield; may miss complex or novel mutations |
Physician Insight & Safety Protocol
“A positive MYH2 mutation can explain a patient’s progressive muscle weakness and guide targeted surveillance, but results must always be correlated with clinical phenotype and electromyography findings. Your neurologist or clinical geneticist will use this report to craft a multidisciplinary care plan that respects your unique health journey. I remind every patient that genetic information is only one piece of the diagnostic puzzle.”
— Dr. Prabhakar Reddy, Consultant Neurologist & Geneticist, DHA License 61713011
⚠️ Medication Warning: Do not discontinue any prescribed medication, especially immunosuppressants or myopathy‑related drugs, without explicit guidance from your treating physician. Abrupt cessation may worsen muscle function.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not suitable as a stand‑alone screen in asymptomatic minors without parental consent and genetic counseling per UAE CDS Law 2026.
- Exclusion: Samples compromised by recent blood transfusion (within 14 days) or allogeneic bone marrow transplant may yield inaccurate germline results.
- ER Red Flag: Sudden worsening of muscle weakness, difficulty swallowing, or respiratory distress warrants immediate emergency evaluation – do not wait for genetic results.
- ER Red Flag: New‑onset cardiac symptoms (palpitations, syncope) in a patient with known MYH2‑related myopathy may indicate cardiac involvement requiring urgent cardiology consult.
Frequently Asked Questions (Patient Guidance)
1. What exactly does the MYH2 Genetic Test detect and how accurate is it?
It sequences all coding exons of the MYH2 gene with 99.9% diagnostic sensitivity, identifying single‑nucleotide variants, small insertions/deletions, and large copy‑number imbalances that cause autosomal dominant inclusion body myopathy.
يقوم التسلسل الجيني الكامل لجين MYH2 بكشف جميع الطفرات المسببة للمرض بدقة تشخيصية تبلغ 99.9%، بما في ذلك التغيرات النقطية والحذف والإدراج والاختلافات في عدد النسخ.
2. How should I prepare for the blood collection, and is an FTA card acceptable?
No fasting is required; a 2–3 mL whole blood sample (EDTA tube) is standard, but a single drop of blood on an FTA card or previously extracted DNA can also be submitted, provided it meets ISO 9001:2015 cold‑chain requirements during transport.
لا حاجة للصيام؛ العينة القياسية هي 2-3 مل من الدم الكامل في أنبوب EDTA، كما يمكن استخدام قطرة دم على بطاقة FTA أو حمض نووي مستخلص سابقاً بشرط الالتزام بسلسلة التبريد المعتمدة ISO 9001:2015.
3. How long will it take to receive my results, and who interprets them?
Results are typically available within 3 to 4 weeks from sample receipt, and a dedicated post‑ telephonic consultation with a clinical geneticist or neurologist is included to explain the findings and implications for your family.
تظهر النتائج عادةً خلال 3 إلى 4 أسابيع من استلام العينة، وتتضمن الخدمة استشارة هاتفية بعد الاختبار مع أخصائي الوراثة السريرية أو طبيب الأعصاب لتفسير النتائج وتأثيراتها العائلية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians